Cellectar Biosciences, Inc.CLRBNASDAQ
Loading
Cash Flow PerformanceCompressed
Percentile Rank7
Studio
Year-over-Year Change

Free cash flow yield

Latest
-300.53%
↓ 79% vs avg
Percentile
P7
Near historical low
Streak
1 yr
Consecutive growthCompressed
Average
-168.26%
Historical baseline
PeriodValueYoY Change
2025-300.53%+31.0%
2024-435.49%-343.5%
2023-98.19%+53.4%
2022-210.92%-240.3%
2021-61.98%-82.5%
2020-33.96%+50.0%
2019-67.86%+73.7%
2018-257.62%-335.7%
2017-59.13%+62.3%
2016-156.88%-